Bristol-Myers Squibb Co. (BMY): Price and Financial Metrics


Bristol-Myers Squibb Co. (BMY): $70.76

0.23 (+0.33%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BMY POWR Grades

  • BMY scores best on the Value dimension, with a Value rank ahead of 96.63% of US stocks.
  • BMY's strongest trending metric is Quality; it's been moving down over the last 177 days.
  • BMY ranks lowest in Momentum; there it ranks in the 3rd percentile.

BMY Stock Summary

  • With a market capitalization of $149,788,149,334, BRISTOL MYERS SQUIBB CO has a greater market value than 98.97% of US stocks.
  • BRISTOL MYERS SQUIBB CO's stock had its IPO on January 1, 1986, making it an older stock than 93.22% of US equities in our set.
  • Over the past twelve months, BMY has reported earnings growth of -284.97%, putting it ahead of just 5.95% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to BRISTOL MYERS SQUIBB CO, a group of peers worth examining would be TXN, NVS, AMGN, SNY, and CSCO.
  • Visit BMY's SEC page to see the company's official filings. To visit the company's web site, go to www.bms.com.

BMY Valuation Summary

  • In comparison to the median Healthcare stock, BMY's price/earnings ratio is 16.33% higher, now standing at 22.8.
  • BMY's EV/EBIT ratio has moved down 27.4 over the prior 243 months.

Below are key valuation metrics over time for BMY.

Stock Date P/S P/B P/E EV/EBIT
BMY 2022-09-23 3.2 4.6 22.8 23.9
BMY 2022-09-22 3.2 4.7 23.0 24.0
BMY 2022-09-21 3.1 4.5 22.4 23.5
BMY 2022-09-20 3.2 4.6 22.5 23.6
BMY 2022-09-19 3.2 4.6 22.6 23.7
BMY 2022-09-16 3.2 4.7 23.1 24.1

BMY Growth Metrics

    Its year over year net cashflow from operations growth rate is now at 15.83%.
  • The 5 year net income to common stockholders growth rate now stands at -71.66%.
  • The year over year net income to common stockholders growth rate now stands at 200.51%.
BMY's revenue has moved up $26,104,000,000 over the prior 52 months.

The table below shows BMY's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 47,144 15,396 6,617
2022-03-31 46,960 16,195 6,251
2021-12-31 46,385 16,207 6,994
2021-09-30 45,468 15,820 -5,405
2021-06-30 44,384 12,773 -5,079
2021-03-31 42,810 13,982 -6,219

BMY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BMY has a Quality Grade of B, ranking ahead of 79.64% of graded US stocks.
  • BMY's asset turnover comes in at 0.38 -- ranking 124th of 680 Pharmaceutical Products stocks.
  • PAHC, ACUR, and XLRN are the stocks whose asset turnover ratios are most correlated with BMY.

The table below shows BMY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.380 0.759 -0.071
2021-03-31 0.353 0.744 -0.072
2020-12-31 0.339 0.723 -0.123
2020-09-30 0.307 0.713 0.062
2020-06-30 0.314 0.696 0.050
2020-03-31 0.334 0.681 0.058

BMY Price Target

For more insight on analysts targets of BMY, see our BMY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $80.06 Average Broker Recommendation 1.47 (Moderate Buy)

BMY Stock Price Chart Interactive Chart >

Price chart for BMY

BMY Price/Volume Stats

Current price $70.76 52-week high $80.59
Prev. close $70.53 52-week low $53.22
Day low $70.76 Volume 1,534
Day high $70.76 Avg. volume 12,979,051
50-day MA $71.82 Dividend yield 3.06%
200-day MA $71.45 Market Cap 151.09B

Bristol-Myers Squibb Co. (BMY) Company Bio


Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. BMS is one of the world's largest pharmaceutical companies, and is consistently ranked on the Fortune 500 list of the largest U.S. corporations. As of September 2020, it had the total revenue of $39.3 billion. (Source:Wikipedia)


BMY Latest News Stream


Event/Time News Detail
Loading, please wait...

BMY Latest Social Stream


Loading social stream, please wait...

View Full BMY Social Stream

Latest BMY News From Around the Web

Below are the latest news stories about BRISTOL MYERS SQUIBB CO that investors may wish to consider to help them evaluate BMY as an investment opportunity.

5 NYSE Stocks To Watch And Buy: Here Are Fundamental And Technical Reasons Why

Based on Monday's view of an IBD-produced screen, they now include small-cap enterprise software firm Model N, lithium metal producer Albemarle, electrical equipment firm Hubbell and trendy footwear and apparel firm Deckers Outdoor. In 2022, the NYSE's composite index continues to outperform its Nasdaq sibling. Since the November 2021 peak in the market, the NYSE composite has fallen as much as 20% from its 17,442 peak.

Yahoo | October 3, 2022

Will New Drugs Help Bristol Myers (BMY) Combat Generic Pressure?

Bristol Myers (BMY) expects recent drug approvals to generate an incremental stream of revenues and combat competition for its key drugs.

Yahoo | October 3, 2022

With 78% institutional ownership, Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst the big guns

If you want to know who really controls Bristol-Myers Squibb Company ( NYSE:BMY ), then you'll have to look at the...

Yahoo | October 2, 2022

Bristol Myers Squibb (BMY) Stock Moves -0.86%: What You Should Know

In the latest trading session, Bristol Myers Squibb (BMY) closed at $71.09, marking a -0.86% move from the previous day.

Yahoo | September 30, 2022

Bristol Myers Squibb (BMY) Stock Moves -0.49%: What You Should Know

In the latest trading session, Bristol Myers Squibb (BMY) closed at $71.71, marking a -0.49% move from the previous day.

Yahoo | September 29, 2022

Read More 'BMY' Stories Here

BMY Price Returns

1-mo 3.13%
3-mo -7.16%
6-mo -7.78%
1-year 22.87%
3-year 51.73%
5-year 28.20%
YTD 16.13%
2021 2.88%
2020 0.41%
2019 27.74%
2018 -12.90%
2017 7.71%

BMY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BMY Dividend History

Continue Researching BMY

Here are a few links from around the web to help you further your research on Bristol Myers Squibb Co's stock as an investment opportunity:

Bristol Myers Squibb Co (BMY) Stock Price | Nasdaq
Bristol Myers Squibb Co (BMY) Stock Quote, History and News - Yahoo Finance
Bristol Myers Squibb Co (BMY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6365 seconds.